Full Text of HB1967 96th General Assembly
HB1967ham001 96TH GENERAL ASSEMBLY
|
Rep. John E. Bradley
Filed: 4/1/2009
|
|
09600HB1967ham001 |
|
LRB096 05326 RLC 25002 a |
|
| 1 |
| AMENDMENT TO HOUSE BILL 1967
| 2 |
| AMENDMENT NO. ______. Amend House Bill 1967 by replacing | 3 |
| everything after the enacting clause with the following:
| 4 |
| "Section 5. The Illinois Controlled Substances Act is | 5 |
| amended by changing Sections 317 and 318 as follows:
| 6 |
| (720 ILCS 570/317)
| 7 |
| Sec. 317. Central repository for collection of | 8 |
| information.
| 9 |
| (a) The Department must designate a central repository for
| 10 |
| the collection of information transmitted under Section 316 and | 11 |
| 321.
| 12 |
| (b) The central repository must do the following:
| 13 |
| (1) Create a database for information required to be | 14 |
| transmitted under
Section 316 in the form required under | 15 |
| rules adopted by the
Department, including search | 16 |
| capability for the following:
|
|
|
|
09600HB1967ham001 |
- 2 - |
LRB096 05326 RLC 25002 a |
|
| 1 |
| (A) A recipient's name.
| 2 |
| (B) A recipient's address.
| 3 |
| (C) The national drug code number of a controlled | 4 |
| substance
dispensed.
| 5 |
| (D) The dates a controlled substance is dispensed.
| 6 |
| (E) The quantities of a controlled substance | 7 |
| dispensed.
| 8 |
| (F) A dispenser's United States Drug Enforcement | 9 |
| Administration
registration number.
| 10 |
| (G) A prescriber's United States Drug Enforcement | 11 |
| Administration
registration number.
| 12 |
| (2) Provide the Department with a database maintained | 13 |
| by the central
repository. The Department of Financial and
| 14 |
| Professional
Regulation must provide the
Department with | 15 |
| electronic access to the license information of a | 16 |
| prescriber or
dispenser. The Department of Financial and
| 17 |
| Professional Regulation may charge a fee for this
access | 18 |
| not to exceed the actual cost of furnishing the | 19 |
| information.
| 20 |
| (3) Secure the information collected by the central | 21 |
| repository and the
database maintained by the central | 22 |
| repository against access by unauthorized
persons. | 23 |
| (c) The Department must retain the information in the | 24 |
| central repository for at least 90 days. | 25 |
| No fee shall be charged for access by a prescriber or | 26 |
| dispenser.
|
|
|
|
09600HB1967ham001 |
- 3 - |
LRB096 05326 RLC 25002 a |
|
| 1 |
| (Source: P.A. 95-442, eff. 1-1-08.)
| 2 |
| (720 ILCS 570/318)
| 3 |
| Sec. 318. Confidentiality of information.
| 4 |
| (a) Information received by the central repository under | 5 |
| Section 316 and 321
is confidential.
| 6 |
| (b) The Department must carry out a program to protect the
| 7 |
| confidentiality of the information described in subsection | 8 |
| (a). The Department
may
disclose the information to another | 9 |
| person only under
subsection (c), (d), or (f) and may charge a | 10 |
| fee not to exceed the actual cost
of
furnishing the
| 11 |
| information.
| 12 |
| (c) The Department may disclose confidential information | 13 |
| described
in subsection (a) to any person who is engaged in | 14 |
| receiving, processing, or
storing the information.
| 15 |
| (d) The Department may release confidential information | 16 |
| described
in subsection (a) to the following persons:
| 17 |
| (1) A governing body
that licenses practitioners and is | 18 |
| engaged in an investigation, an
adjudication,
or a | 19 |
| prosecution of a violation under any State or federal law | 20 |
| that involves a
controlled substance.
| 21 |
| (2) An investigator for the Consumer Protection | 22 |
| Division of the office of
the Attorney General, a | 23 |
| prosecuting attorney, the Attorney General, a deputy
| 24 |
| Attorney General, or an investigator from the office of the | 25 |
| Attorney General,
who is engaged in any of the following |
|
|
|
09600HB1967ham001 |
- 4 - |
LRB096 05326 RLC 25002 a |
|
| 1 |
| activities involving controlled
substances:
| 2 |
| (A) an investigation;
| 3 |
| (B) an adjudication; or
| 4 |
| (C) a prosecution
of a violation under any State or | 5 |
| federal law that involves a controlled
substance.
| 6 |
| (3) A law enforcement officer who is:
| 7 |
| (A) authorized by the Department of State Police or | 8 |
| the office of a county sheriff or State's Attorney or
| 9 |
| municipal police department of Illinois to receive
| 10 |
| information
of the type requested for the purpose of | 11 |
| investigations involving controlled
substances; or
| 12 |
| (B) approved by the Department to receive | 13 |
| information of the
type requested for the purpose of | 14 |
| investigations involving controlled
substances; and
| 15 |
| (C) engaged in the investigation or prosecution of | 16 |
| a violation
under
any State or federal law that | 17 |
| involves a controlled substance.
| 18 |
| (e) Before the Department releases confidential | 19 |
| information under
subsection (d), the applicant must | 20 |
| demonstrate in writing to the Department that:
| 21 |
| (1) the applicant has reason to believe that a | 22 |
| violation under any
State or
federal law that involves a | 23 |
| controlled substance has occurred; and
| 24 |
| (2) the requested information is reasonably related to | 25 |
| the investigation,
adjudication, or prosecution of the | 26 |
| violation described in subdivision (1).
|
|
|
|
09600HB1967ham001 |
- 5 - |
LRB096 05326 RLC 25002 a |
|
| 1 |
| The provisions of this subsection (e) do not apply to a law | 2 |
| enforcement officer authorized to obtain access to the | 3 |
| confidential information under subparagraph (A) of paragraph | 4 |
| (3) of subsection (d) of this Section. | 5 |
| (f) The Department may receive and release prescription | 6 |
| record information to:
| 7 |
| (1) a governing
body that licenses practitioners;
| 8 |
| (2) an investigator for the Consumer Protection | 9 |
| Division of the office of
the Attorney General, a | 10 |
| prosecuting attorney, the Attorney General, a deputy
| 11 |
| Attorney General, or an investigator from the office of the | 12 |
| Attorney General;
| 13 |
| (3) any Illinois law enforcement officer who is:
| 14 |
| (A) authorized to receive the type of
information | 15 |
| released; and
| 16 |
| (B) (blank) approved by the Department to receive | 17 |
| the type of
information released ; or
| 18 |
| (4) prescription monitoring entities in other states | 19 |
| per the provisions outlined in subsection (g) and (h) | 20 |
| below;
| 21 |
| confidential prescription record information collected under | 22 |
| Sections 316 and 321 that identifies vendors or
practitioners, | 23 |
| or both, who are prescribing or dispensing large quantities of
| 24 |
| Schedule II, III, IV, or V controlled
substances outside the | 25 |
| scope of their practice, pharmacy, or business, as determined | 26 |
| by the Advisory Committee created by Section 320.
|
|
|
|
09600HB1967ham001 |
- 6 - |
LRB096 05326 RLC 25002 a |
|
| 1 |
| (g) The information described in subsection (f) may not be | 2 |
| released until it
has been reviewed by an employee of the | 3 |
| Department who is licensed as a
prescriber or a dispenser
and | 4 |
| until that employee has certified
that further investigation is | 5 |
| warranted. However, failure to comply with this
subsection (g) | 6 |
| does not invalidate the use of any evidence that is otherwise
| 7 |
| admissible in a proceeding described in subsection (h).
| 8 |
| (h) An investigator or a law enforcement officer receiving | 9 |
| confidential
information under subsection (c), (d), or (f) may | 10 |
| disclose the information to a
law enforcement officer or an | 11 |
| attorney for the office of the Attorney General
for use as | 12 |
| evidence in the following:
| 13 |
| (1) A proceeding under any State or federal law that | 14 |
| involves a
controlled substance.
| 15 |
| (2) A criminal proceeding or a proceeding in juvenile | 16 |
| court that involves
a controlled substance.
| 17 |
| (i) The Department may compile statistical reports from the
| 18 |
| information described in subsection (a). The reports must not | 19 |
| include
information that identifies, by name, license or | 20 |
| address, any practitioner, dispenser, ultimate user, or other | 21 |
| person
administering a controlled substance.
| 22 |
| (j) Based upon federal, initial and maintenance funding, a | 23 |
| prescriber and dispenser inquiry system shall be developed to | 24 |
| assist the medical community in its goal of effective clinical | 25 |
| practice and to prevent patients from diverting or abusing | 26 |
| medications.
|
|
|
|
09600HB1967ham001 |
- 7 - |
LRB096 05326 RLC 25002 a |
|
| 1 |
| (1) An inquirer shall have read-only access to a | 2 |
| stand-alone database which shall contain records for the | 3 |
| previous 6 months. | 4 |
| (2) Dispensers may, upon positive and secure | 5 |
| identification, make an inquiry on a patient or customer | 6 |
| solely for a medical purpose as delineated within the | 7 |
| federal HIPAA law. | 8 |
| (3) The Department shall provide a one-to-one secure | 9 |
| link and encrypted software necessary to establish the link | 10 |
| between an inquirer and the Department. Technical | 11 |
| assistance shall also be provided. | 12 |
| (4) Written inquiries are acceptable but must include | 13 |
| the fee and the requestor's Drug Enforcement | 14 |
| Administration license number and submitted upon the | 15 |
| requestor's business stationary. | 16 |
| (5) No data shall be stored in the database beyond 24 | 17 |
| months. | 18 |
| (6) Tracking analysis shall be established and used per | 19 |
| administrative rule. | 20 |
| (7) Nothing in this Act or Illinois law shall be | 21 |
| construed to require a prescriber or dispenser to make use | 22 |
| of this inquiry system.
| 23 |
| (8) If there is an adverse outcome because of a | 24 |
| prescriber or dispenser making an inquiry, which is | 25 |
| initiated in good faith, the prescriber or dispenser shall | 26 |
| be held harmless from any civil liability.
|
|
|
|
09600HB1967ham001 |
- 8 - |
LRB096 05326 RLC 25002 a |
|
| 1 |
| (Source: P.A. 95-442, eff. 1-1-08.)".
|
|